GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Akdital (CAS:AKT) » Definitions » Net Income Including Noncontrolling Interests

Akdital (CAS:AKT) Net Income Including Noncontrolling Interests : MAD145 Mil (TTM As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Akdital Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Akdital's Net Income Including Noncontrolling Interests for the six months ended in Jun. 2023 was MAD75 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2023 was MAD145 Mil.


Akdital Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Akdital's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akdital Net Income Including Noncontrolling Interests Chart

Akdital Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Net Income Including Noncontrolling Interests
6.76 27.59 46.40 98.57

Akdital Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial 13.06 30.44 28.40 70.17 74.82

Akdital Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was MAD145 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akdital Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Akdital's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.


Akdital (CAS:AKT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Akdital (CAS:AKT) » Definitions » Net Income Including Noncontrolling Interests
Traded in Other Exchanges
N/A
Address
258 Route de l’Oasis, Casablanca, MAR, 20250
Akdital operates private healthcare clinics. The company offers healthcare services such as cardiac surgery, neurosurgery, oncology, radiotherapy, intensive care, and neonatal care, providing patients with comprehensive care according to international standards.

Akdital (CAS:AKT) Headlines

From GuruFocus

Everspan Group Announces Retirement of Wyatt Blackburn

By Business Wire Business Wire 11-29-2022

Ambac Settles RMBS Litigation Against Nomura

By Business Wire Business Wire 01-03-2023

Ambac Reports Second Quarter 2023 Results

By Business Wire 08-07-2023

Ambac Names Naveen Anand President of Cirrata Group

By Business Wire Business Wire 05-09-2023

Penny Parisoff Partners With Ambac to Create Human Services-Focused MGA

By Business Wire Business Wire 06-30-2022

Ambac Releases Statement Regarding Speculative Acquisition Report

By Business Wire Business Wire 12-08-2022